-transparent.png){kind=logo}
A double-blind comparison of two intravenous cholangiocholecystographic agents of similar molecular structure, meglumine iodoxamate and meglumine iodipamide, was carried out in 90 patients. Each produced a comparably high percentage of satisfactory examinations. A similar pattern of excretion speed and intensity was noted for each, though meglumine iodoxamate appeared to be slightly more effective in patients with elevated serum bilirubin. Less evidence of hepatic toxicity and fewer and less serious adverse side effects were observed in patients given the newer agent, meglumine iodoxamate.
Related Publications
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
April 1977,
Annals of internal medicine,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
October 1975,
Radiology,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
January 1979,
AJR. American journal of roentgenology,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
January 1981,
Diagnostic imaging,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
July 1979,
The American journal of gastroenterology,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
June 1977,
AJR. American journal of roentgenology,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
June 1974,
JAMA,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
January 1961,
The American journal of roentgenology, radium therapy, and nuclear medicine,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
August 1978,
The British journal of radiology,
A H Robbins, and
E N Sargent, and
M E Vincent, and
W Boswell, and
H I Meyers
February 1977,
AJR. American journal of roentgenology,
